Most Popular Stories
Poll
Featured Jobs
-
Tennessee Family Practice
StaffPointe, LLC - east , TN -
Oklahoma Pediatrician
StaffPointe, LLC - north, OK -
Nurse Practitioner or CNS in Michigan
StaffPointe, LLC - southwest , MI -
Phamacy Auditor
Pharm/DUR, Inc. - Philadelphia, PA -
Washington Family Medicine
StaffPointe, LLC - Seattle , WA
Events
- World Health Care Congress
April 14-16, 2009 — Washington, DC - World Healthcare Innovation & Technology Congress WHIT v.4.0
Dec 8-10 — Washington, DC
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies
Popular Topics
Report: Medicaid study wasted $275M
In 2005, a yearlong federal government study paid cancer doctors a combined $275 million for assessing their patient's side effects from chemotherapy. Now many other doctors and lawmakers feel that the study was a waste of money and that its findings will be of no real use to healthcare providers. Chemotherapy providers were given $130 every time they reported their patients' side effects. But HHS Inspector General Daniel Levinson noted, "we identified numerous anomalies and gaps in the data and collection methods." Doctors were reimbursed a median of $23,000, with some receiving ten times that. Medicaid officials defend the program, saying it successfully managed to get doctors to report on quality data. This data can lead to process improvement and better outcomes in the future.
For more on the controversy:
- read this report from the AP
Related Stories
- Gov't: Pharmaco bilked CMS out of $500M
- Doctors consider impact of Medicare incentives
- Physician Medicare cut may be eliminated
- Medicare cuts service fees for MDs
- Federal fraud program nabs $1.47B
- Study: Residents work too many hours
- Two providers settle whistle-blower suits
- Study: Americans have many healthcare concerns
- Calif. lawmakers want more transplant oversight
- Consumers reluctant to use outcomes, cost data
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceSarbox | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceBiotech | FierceBioResearcher | FiercePharma | FierceVaccines | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2008 FierceMarkets, Inc. All rights reserved. |
![]() |





